Coherus and Superior Biologics Announce National Distribution Agreement for YUSIMRY™
13. Juli 2023 08:30 ET
|
Coherus BioSciences, Inc.
First formal distribution agreement for YUSIMRY™, a biosimilar of Humira®, at $995 per carton (two 40 mg/0.8 mL autoinjectors) representing a discount of more than 85% compared to HumiraInnovative...